BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©Author(s) (or their employer(s)) 2026.
World J Gastrointest Surg. Feb 27, 2026; 18(2): 114483
Published online Feb 27, 2026. doi: 10.4240/wjgs.v18.i2.114483
Table 1 Univariate analysis results between patients with and without postoperative gastrointestinal dysfunction in gastrointestinal tumor patients
Variable
Non-dysfunction group (n = 124)
Dysfunction group (n = 52)
t value
P value
Age (years)58.2 ± 8.565.3 ± 7.85.231< 0.001
Gender (male/female)72/5238/144.3250.038
BMI (kg/m2)23.5 ± 2.121.8 ± 2.34.1230.043
Tumor location (stomach/intestine)68/5632/200.2340.629
Tumor stage (I-II/III-IV)86/3824/285.6780.017
Surgical approach (open/laparoscopic)45/7922/301.2340.267
Operation time (minute)180.5 ± 30.2210.3 ± 35.64.876< 0.001
Pre-operative hemoglobin (g/L)125.3 ± 15.6108.2 ± 12.36.345< 0.001
Pre-operative albumin (g/L)38.5 ± 3.234.2 ± 3.57.234< 0.001
Table 2 Multivariate Logistic regression analysis of independent risk factors for postoperative gastrointestinal dysfunction in patients with gastrointestinal tumors
Variable
B
SE
Wald
df
P value
OR
95%CI
Age (year)0.0850.0327.12310.0081.0891.023-1.160
Gender (male vs female)0.8520.3456.12310.0132.3461.182-4.658
BMI (kg/m2)-0.2340.1025.23410.0220.7920.645-0.978
Tumor stage (III-IV vs I-II)1.2340.4567.45610.0063.4321.412-8.321
Operation time (minute)0.0120.0048.23410.0041.0121.004-1.020
Pre-operative hemoglobin (g/L)-0.0230.0088.12310.0040.9770.962-0.993
Pre-operative albumin (g/L)-0.1560.0528.98710.0030.8560.765-0.954
Table 3 Receiver operating characteristic curve analysis results of the risk prediction model for postoperative gastrointestinal dysfunction in patients with gastrointestinal tumors
Index
AUC
95%CI
P value
Optimal cut-off value
Sensitivity (%)
Specificity (%)
Prediction model0.8950.842-0.9480.0000.45682.385.6
Table 4 Effect of preventive management measures based on the risk prediction model on the incidence of postoperative gastrointestinal dysfunction in patients with gastrointestinal tumors
Group
n
Number of cases with postoperative gastrointestinal dysfunction
Incidence (%)
χ²
P value
Intervention group601220.08.2340.004
Control group602846.78.2340.004